• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者及对照组支气管活检中的炎症细胞与重塑

Inflammatory cells and remodeling in bronchial biopsies from COPD patients and controls.

作者信息

Eagan Tomas M, Nielsen Rune, Haaland Ingvild, Husebø Gunnar R, Lehmann Sverre, Ward Jon A, Wilson Susan J

机构信息

Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.

Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.

出版信息

PLoS One. 2025 Jun 17;20(6):e0326267. doi: 10.1371/journal.pone.0326267. eCollection 2025.

DOI:10.1371/journal.pone.0326267
PMID:40526700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12173230/
Abstract

BACKGROUND

The understanding of inflammation and remodeling in the bronchial wall of COPD patients with varying disease severity remains incomplete.

METHODS

35 healthy controls and 47 volunteer COPD patients underwent bronchoscopy with bronchoalveolar lavage (BAL) and sampling by endobronchial biopsies in 2014-2015 as part of the MicroCOPD Study. Biopsies were embedded in glycol methyl acrylate (GMA) resin and examined by immunohistochemistry and staining for enumeration of CD3 + , CD4 + , CD8 + , CD20 + , CD68 + , EG2 + , and NE+ inflammatory cells, as well as endothelial cells (EN4) and smooth muscle actin (SMA). Mucus cells were stained by periodic acid-schiff (PAS), and toluidine blue to visualize the reticular basement membrane (RBM).

RESULTS

The numbers of macrophages and eosinophils were higher, and vascularity increased in the submucosa in COPD patients compared with healthy controls. In healthy smokers there were lower numbers of lymphocytes (CD3 +, CD4 +, CD8 +, CD20+) than never smokers. However, COPD patients with GOLD I/II had higher numbers of eosinophils and larger smooth muscle area compared with GOLD III/IV. COPD exacerbations the last year, blood eosinophils, and use of inhaled corticosteroids did not affect levels of inflammation or remodeling.

CONCLUSION

Smoking alters inflammation in healthy controls, while specific patterns of macrophages, eosinophils, and vascularity distinguish COPD from non-COPD in bronchial biopsies.

摘要

背景

对于不同疾病严重程度的慢性阻塞性肺疾病(COPD)患者支气管壁炎症和重塑的理解仍不完整。

方法

作为MicroCOPD研究的一部分,35名健康对照者和47名COPD志愿者在2014年至2015年接受了支气管镜检查,包括支气管肺泡灌洗(BAL)和经支气管活检取样。活检组织包埋于甲基丙烯酸乙二醇酯(GMA)树脂中,通过免疫组织化学和染色来计数CD3 +、CD4 +、CD8 +、CD20 +、CD68 +、EG2 +和NE +炎症细胞,以及内皮细胞(EN4)和平滑肌肌动蛋白(SMA)。黏液细胞用高碘酸 - 希夫(PAS)染色,甲苯胺蓝染色以观察网状基底膜(RBM)。

结果

与健康对照者相比,COPD患者巨噬细胞和嗜酸性粒细胞数量增加,黏膜下层血管增多。健康吸烟者的淋巴细胞(CD3 +、CD4 +、CD8 +、CD20 +)数量低于从不吸烟者。然而,与GOLD III/IV级COPD患者相比,GOLD I/II级患者嗜酸性粒细胞数量更多,平滑肌面积更大。过去一年的COPD急性加重、血液嗜酸性粒细胞水平及吸入性糖皮质激素的使用并未影响炎症或重塑水平。

结论

吸烟改变健康对照者的炎症状态,而巨噬细胞、嗜酸性粒细胞和血管的特定模式在支气管活检中可区分COPD与非COPD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/e4848d69656e/pone.0326267.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/6658df5d6739/pone.0326267.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/96dee022dd9b/pone.0326267.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/e4848d69656e/pone.0326267.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/6658df5d6739/pone.0326267.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/96dee022dd9b/pone.0326267.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ab/12173230/e4848d69656e/pone.0326267.g003.jpg

相似文献

1
Inflammatory cells and remodeling in bronchial biopsies from COPD patients and controls.慢性阻塞性肺疾病(COPD)患者及对照组支气管活检中的炎症细胞与重塑
PLoS One. 2025 Jun 17;20(6):e0326267. doi: 10.1371/journal.pone.0326267. eCollection 2025.
2
Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019).接受吸入三联疗法时发生急性加重的慢性阻塞性肺疾病患者的特征和结局:美国SIRIUS I队列研究(2015 - 2019年)的结果
Int J Chron Obstruct Pulmon Dis. 2025 Jun 11;20:1851-1864. doi: 10.2147/COPD.S513573. eCollection 2025.
3
Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study.基底膜和血管重构在吸烟者和慢性阻塞性肺疾病中的作用:一项横断面研究。
Respir Res. 2010 Jul 30;11(1):105. doi: 10.1186/1465-9921-11-105.
4
Association of Patient-Reported Outcome Patterns and Major Clinical Factors with Frailty in Stable COPD.稳定期慢性阻塞性肺疾病患者报告结局模式及主要临床因素与衰弱的关联
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1927-1937. doi: 10.2147/COPD.S517270. eCollection 2025.
5
Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.在当前吸烟者和已确诊 COPD 的戒烟者中,使用痰、BAL 和支气管内膜活检评估气道炎症。
Int J Chron Obstruct Pulmon Dis. 2010 Oct 5;5:327-34. doi: 10.2147/COPD.S11343.
6
Inflammatory features of nasal mucosa in smokers with and without COPD.患有慢性阻塞性肺疾病(COPD)和未患COPD的吸烟者鼻黏膜的炎症特征
Thorax. 2004 Apr;59(4):303-7. doi: 10.1136/thx.2003.006650.
7
Mucolytics for children with chronic suppurative lung disease.用于患有慢性化脓性肺病儿童的黏液溶解剂。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD015313. doi: 10.1002/14651858.CD015313.pub2.
8
Burden of Exacerbations in Patients Newly Initiating an Inhaled Regimen for COPD: A Claims Analysis.慢性阻塞性肺疾病(COPD)新开始吸入治疗方案患者的急性加重负担:一项索赔分析。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 7;20:1829-1842. doi: 10.2147/COPD.S517864. eCollection 2025.
9
Protective effect of Astragaloside II against lung injury in COPD based on mTORC1/GSK-3β signaling pathway.基于mTORC1/GSK-3β信号通路探讨黄芪甲苷II对慢性阻塞性肺疾病肺损伤的保护作用
Eur J Pharmacol. 2025 Feb 5;988:177214. doi: 10.1016/j.ejphar.2024.177214. Epub 2024 Dec 18.
10
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials.恩昔芬净治疗慢性阻塞性肺疾病的疗效与安全性:一项临床试验的系统评价和荟萃分析
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251347775. doi: 10.1177/17534666251347775. Epub 2025 Jun 20.

本文引用的文献

1
Relationships between Airway Remodeling and Clinical Characteristics in COPD Patients.慢性阻塞性肺疾病患者气道重塑与临床特征的关系
Biomedicines. 2022 Aug 17;10(8):1992. doi: 10.3390/biomedicines10081992.
2
Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis.ICS 降低 COPD 临床重要恶化风险依赖于嗜酸性粒细胞:一项汇总的事后分析。
Respir Res. 2020 Jan 10;21(1):17. doi: 10.1186/s12931-020-1280-y.
3
Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD.
嗜酸粒细胞和中性粒细胞对 COPD 患者 ICS 临床疗效的预测价值。
Respirology. 2018 Nov;23(11):1023-1031. doi: 10.1111/resp.13312. Epub 2018 Apr 26.
4
Exacerbations of COPD.COPD 恶化。
Eur Respir Rev. 2018 Mar 14;27(147). doi: 10.1183/16000617.0103-2017. Print 2018 Mar 31.
5
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.慢性阻塞性肺疾病患者加重风险和布地奈德治疗反应的预测因素:三项随机试验的事后分析。
Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10.
6
Influence of Inhaled Corticosteroids on Bronchial Inflammation and Pulmonary Function in Chronic Obstructive Pulmonary Disease with Moderate Obstruction.吸入性皮质类固醇对中重度阻塞性肺疾病支气管炎症及肺功能的影响。
Adv Exp Med Biol. 2018;1047:41-52. doi: 10.1007/5584_2017_129.
7
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.长期停用吸入性糖皮质激素后慢性阻塞性肺疾病患者的气道炎症
Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.00848-2017. Print 2017 Jun.
8
Effect of a single exacerbation on decline in lung function in COPD.单次加重对慢性阻塞性肺疾病肺功能下降的影响。
Respir Med. 2017 Jul;128:85-91. doi: 10.1016/j.rmed.2017.04.013. Epub 2017 Apr 24.
9
Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD.剖析轻度至中度慢性阻塞性肺疾病气道壁中的细胞及炎症变化。
Respirology. 2017 Aug;22(6):1125-1132. doi: 10.1111/resp.13021. Epub 2017 Mar 22.
10
Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD.吸入性糖皮质激素可使慢性阻塞性肺疾病(COPD)患者部分而非全部气道血管重塑恢复正常。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 22;11:2359-2367. doi: 10.2147/COPD.S113176. eCollection 2016.